COVID-19 Vaccine Trial (needle free)

In this trial, we are evaluating the safety and tolerability of a new investigational DNA vaccine to protect against SARS CoV-2 virus. As you are aware, this virus has caused an outbreak of an illness called coronavirus disease-19 (called “COVID‑19”) around the world. In this study, it is the first time that this particular vaccine is given to humans.

This study will require 8 clinic visits and 2 telephone calls over a twelve month period.

To be eligible you must:

  • Be a healthy male or healthy female who is not pregnant or who cannot bear children
  • Aged 18-75 (inclusive)

If you meet the criteria for this study and would like more information, register below or call 1800 727 874.

To view the Media release for this trial, please click here.

Be a healthy male or female
Must comply with contraception requirements
Aged 18 to 75 years